Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning and Dissemination Grant - Institute Community Support

Université de Sherbrooke

$15,000.00

Chronic Inflammation, Immunity and Cancer 2019

EF 2018-19

Résumé
Gut diseases have a huge impact on the Canadian health care system cost. Indeed, Canada has among the highest rates of intestinal inflammatory bowel diseases (IBD) in the world with approximately 233 thousands of people that were living with it in 2012. Colorectal cancer (CRC) is the second most commonly diagnosed cancer in Canada, accounting for over 12% of cancer deaths in the population. It is now clear that defects in the immune system as well as in the epithelium homeostasis are central to both of these gastrointestinal diseases. The Chronic Inflammation, Immunity and Cancer (CIIC) 2019 initiative is the culmination of a series of Digestive Physiopathology annual symposia that have been held since 2001 to gather active researchers and trainees in the field of basic and clinical research in gastroenterology. The expected outcome of CIIC 2019 is to create new task forces among experts in chronic inflammation, immunity and cancer and to steer these scientific interactions to deliver on collaboration, integration, excellence, and innovation in the gastrointestinal research field.
Programme
Planning and Dissemination Grant - Institute Community Support
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
404372
Name
Boudreau François
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Planning and Dissemination - INMD
Projecttitle
Chronic Inflammation, Immunity and Cancer 2019
Programtype2
Miscellaneous Programs
Orgnameinp2
Université de Sherbrooke
Cihramount2
$15,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Biological Models; Digestive Cancer; Immunotherapy; Inflammatory Bowel Diseases; Mechanisms Of Inflammation; Microbiome
Abstract
Gut diseases have a huge impact on the Canadian health care system cost. Indeed, Canada has among the highest rates of intestinal inflammatory bowel diseases (IBD) in the world with approximately 233 thousands of people that were living with it in 2012. Colorectal cancer (CRC) is the second most commonly diagnosed cancer in Canada, accounting for over 12% of cancer deaths in the population. It is now clear that defects in the immune system as well as in the epithelium homeostasis are central to both of these gastrointestinal diseases. The Chronic Inflammation, Immunity and Cancer (CIIC) 2019 initiative is the culmination of a series of Digestive Physiopathology annual symposia that have been held since 2001 to gather active researchers and trainees in the field of basic and clinical research in gastroenterology. The expected outcome of CIIC 2019 is to create new task forces among experts in chronic inflammation, immunity and cancer and to steer these scientific interactions to deliver on collaboration, integration, excellence, and innovation in the gastrointestinal research field.
Competitiondate
201903
Approvedterm2
1 yr 0 mth
Pinamesdelim
Boudreau, François
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Nutr Metabolism &Diab~ $15,000~ $0~